Donepezil hydrochloride

STL1267 is a potent and cross-the-blood-brain barrier REV-ERB agonist with a K i value of 0.16 µM for REV-ERBα. STL1267 shows no cytotoxicity. STL1267 inhibits the gene expression of BMAL1In VitroSTL1267 (5 µM: 24 h) decreases the expression of

STL1267 is a potent and cross-the-blood-brain barrier REV-ERB agonist with a K i value of 0.16 µM for REV-ERBα. STL1267 shows no cytotoxicity. STL1267 inhibits the gene expression of BMAL1In VitroSTL1267 (5 µM: 24 h) decreases the expression of

STL1267 is a potent and cross-the-blood-brain barrier REV-ERB agonist with a K i value of 0.16 µM for REV-ERBα. STL1267 shows no cytotoxicity. STL1267 inhibits the gene expression of BMAL1In VitroSTL1267 (5 µM: 24 h) decreases the expression of

STL1267 is a potent and cross-the-blood-brain barrier REV-ERB agonist with a K i value of 0.16 µM for REV-ERBα. STL1267 shows no cytotoxicity. STL1267 inhibits the gene expression of BMAL1In VitroSTL1267 (5 µM: 24 h) decreases the expression of

STL1267 is a potent and cross-the-blood-brain barrier REV-ERB agonist with a K i value of 0.16 µM for REV-ERBα. STL1267 shows no cytotoxicity. STL1267 inhibits the gene expression of BMAL1In VitroSTL1267 (5 µM: 24 h) decreases the expression of

Application Topotecan has been used as a positive control for the identification and analysis of HIF-1&#945: and VEGF inhibitors in human glioma cells under hypoxic conditions 1 . It has also been used for in vitro apoptosis assays in PA317

Application Topotecan has been used as a positive control for the identification and analysis of HIF-1&#945: and VEGF inhibitors in human glioma cells under hypoxic conditions 1 . It has also been used for in vitro apoptosis assays in PA317

InformationTP0463518 TP0463518 is a potent hypoxia-inducible factor prolyl hydroxylases (PHDs) inhibitor with Ki of 5.3 nM for human PHD2. TP0463518 inhibits human PHD1, human PHD3 and monkey PHD2 with IC50 of 18 nM, 63 nM and 22 nM,